Daftar Login

MBS303CD20CD3 - Pharmcube

MEREK : mbs303

MBS303CD20CD3 - Pharmcube

mbs303MBS-303: a CD20 inhibitors, CD3 stimulants Drug, Initially developed by Beijing Mabworks Biotech Co., Ltd.,MBS 303 is a bispecific antibody targeting CD3CD20 being developed by Beijing Mabworks Biotech for the treatment of B cell non-Hodgkin lymphoma. The

IDR 10.000
IDR 100.000 Disc -90%
Kuantitas